| abstract |
In particular, salts of optically active acid and 8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine useful for weight management, and pharmaceutical compositions containing them. One embodiment of the present invention is (R) -8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine (1S)-(+)-10-cansylate Yes, this salt has an X-ray powder diffraction pattern with peaks at about 18.25 °, about 16.45 °, and about 18.57 ° with respect to 2θ. |